Global Metabolomics Market Size, Share, Trends, Analysis: By Product and Services: Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services; By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Others; By Indication; By End User; Regional Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Metabolomics Market Overview 
    3.1    Global Metabolomics Market Historical Value (2017-2023) 
    3.2    Global Metabolomics Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Metabolomics Market Landscape*
    5.1    Global Metabolomics Market: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Metabolomics Market: Product Landscape
        5.2.1    Analysis by Product and Services    
        5.2.2    Analysis by Application
        5.2.3    Analysis by Indication
6    Global Metabolomics Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis
        6.3.1    Political
        6.3.2    Economic
        6.3.3    Social
        6.3.4    Technological
        6.3.5    Legal
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Metabolomics Market Segmentation (2017-2032)
    7.1    Global Metabolomics Market (2017-2032) by Product and Services
        7.1.1    Market Overview
        7.1.2    Metabolomics Instruments
            7.1.2.1    Separation Tools
            7.1.2.2    Detection Tools
        7.1.3    Metabolomics Bioinformatics Tools and Services
    7.2    Global Metabolomics Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Biomarker Discovery
        7.2.3    Drug Discovery
        7.2.4    Toxicology Testing
        7.2.5    Nutrigenomics
        7.2.6    Functional Genomics
        7.2.7    Personalized Medicine
        7.2.8    Other Applications
    7.3    Global Metabolomics Market (2017-2032) by Indication
        7.3.1    Market Overview
        7.3.2    Cancer
        7.3.3    Cardiovascular Disorders
        7.3.4    Neurological Disorders
        7.3.5    Inborn Errors of Metabolism
        7.3.6    Other Indications
    7.4    Global Metabolomics Market (2017-2032) by End User
        7.4.1    Market Overview
        7.4.2    Pharmaceutical and Biotechnology Companies
        7.4.3    Contract Research Organizations
        7.4.4    Others
    7.5    Global Metabolomics Market (2017-2032) by Region
        7.5.1    Market Overview
        7.5.2    North America
        7.5.3    Europe 
        7.5.4    Asia Pacific
        7.5.5    Latin America
        7.5.6    Middle East and Africa
8    North America Metabolomics Market (2017-2032)
    8.1    North America Metabolomics Market (2017-2032) by Product and Services
        8.1.1    Market Overview    
        8.1.2    Metabolomics Instruments
            8.1.2.1    Separation Tools
            8.1.2.2    Detection Tools
        8.1.3    Metabolomics Bioinformatics Tools and Services
    8.2    North America Metabolomics Market (2017-2032) by Application
        8.2.1    Market Overview    
        8.2.2    Biomarker Discovery
        8.2.3    Drug Discovery
        8.2.4    Toxicology Testing
        8.2.5    Nutrigenomics
        8.2.6    Functional Genomics
        8.2.7    Personalized Medicine
        8.2.8    Other Applications
    8.3    North America Metabolomics Market (2017-2032) by Country
        8.3.1    United States of America
        8.3.2    Canada
9    Europe Metabolomics Market (2017-2032)
    9.1    Europe Metabolomics Market (2017-2032) by Product and Services
        9.1.1    Market Overview    
        9.1.2    Metabolomics Instruments
            9.1.2.1    Separation Tools
            9.1.2.2    Detection Tools
        9.1.3    Metabolomics Bioinformatics Tools and Services
    9.2    Europe Metabolomics Market (2017-2032) by Application
        9.2.1    Market Overview    
        9.2.2    Biomarker Discovery
        9.2.3    Drug Discovery
        9.2.4    Toxicology Testing
        9.2.5    Nutrigenomics
        9.2.6    Functional Genomics
        9.2.7    Personalized Medicine
        9.2.8    Other Applications
    9.3    Europe Metabolomics Market (2017-2032) by Country
        9.3.1    United Kingdom
        9.3.2    Germany
        9.3.3    France
        9.3.4    Italy
        9.3.5    Others
10    Asia Pacific Metabolomics Market (2017-2032)
    10.1    Asia Pacific Metabolomics Market (2017-2032) by Product and Services
        10.1.1    Market Overview    
        10.1.2    Metabolomics Instruments
            10.1.2.1    Separation Tools
            10.1.2.2    Detection Tools
        10.1.3    Metabolomics Bioinformatics Tools and Services
    10.2    Asia Pacific Metabolomics Market (2017-2032) by Application
        10.2.1    Market Overview    
        10.2.2    Biomarker Discovery
        10.2.3    Drug Discovery
        10.2.4    Toxicology Testing
        10.2.5    Nutrigenomics
        10.2.6    Functional Genomics
        10.2.7    Personalized Medicine
        10.2.8    Other Applications
    10.3    Asia Pacific Metabolomics Market (2017-2032) by Country
        10.3.1    China
        10.3.2    Japan
        10.3.3    India
        10.3.4    ASEAN
        10.3.5    Australia
        10.3.6    Others
11    Latin America Metabolomics Market (2017-2032)
    11.1     Latin America Metabolomics Market (2017-2032) by Product and Services
        11.1.1    Market Overview    
        11.1.2    Metabolomics Instruments
            11.1.2.1    Separation Tools
            11.1.2.2    Detection Tools
        11.1.3    Metabolomics Bioinformatics Tools and Services
    11.2    Latin America Metabolomics Market (2017-2032) by Application
        11.2.1    Market Overview    
        11.2.2    Biomarker Discovery
        11.2.3    Drug Discovery
        11.2.4    Toxicology Testing
        11.2.5    Nutrigenomics
        11.2.6    Functional Genomics
        11.2.7    Personalized Medicine
        11.2.8    Other Applications
    11.3     Latin America Metabolomics Market (2017-2032) by Country
        11.3.1    Brazil
        11.3.2    Argentina
        11.3.3    Mexico
        11.3.4    Others
12    Middle East and Africa Metabolomics Market (2017-2032)
    12.1     Middle East and Africa Metabolomics Market (2017-2032) by Product and Services
        12.1.1    Market Overview    
        12.1.2    Metabolomics Instruments
            12.1.2.1    Separation Tools
            12.1.2.2    Detection Tools
        12.1.3    Metabolomics Bioinformatics Tools and Services
    12.2    Middle East and Africa Metabolomics Market (2017-2032) by Application
        12.2.1    Market Overview    
        12.2.2    Biomarker Discovery
        12.2.3    Drug Discovery
        12.2.4    Toxicology Testing
        12.2.5    Nutrigenomics
        12.2.6    Functional Genomics
        12.2.7    Personalized Medicine
        12.2.8    Other Applications
    12.3     Middle East and Africa Metabolomics Market (2017-2032) by Country
        12.3.1    Saudi Arabia
        12.3.2    United Arab Emirates
        12.3.3    Nigeria
        12.3.4    South Africa
        12.3.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Patent Analysis
    14.1     Analysis by Type of Patent
    14.2     Analysis by Publication Year
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Patent Age
    14.5     Analysis by CPC Analysis
    14.6     Analysis by Patent Valuation 
    14.7     Analysis by Key Players
15    Grants Analysis
    15.1     Analysis by Year
    15.2     Analysis by Amount Awarded
    15.3     Analysis by Issuing Authority
    15.4     Analysis by Grant Application
    15.5     Analysis by Funding Institute
    15.6     Analysis by Departments
    15.7     Analysis by Recipient Organization 
16    Funding and Investment Analysis
    16.1     Analysis by Funding Instances
    16.2     Analysis by Type of Funding
    16.3     Analysis by Funding Amount
    16.4     Analysis by Leading Players
    16.5     Analysis by Leading Investors
    16.6     Analysis by Geography
17    Strategic Initiatives
    17.1     Analysis by Partnership Instances
    17.2     Analysis by Type of Partnership
    17.3     Analysis by Leading Players
    17.4     Analysis by Geography
18    Supplier Landscape
    18.1     Market Share Analysis, By Region (Top 5 Companies)
        18.1.1    Market Share Analysis: Global
        18.1.2    Market Share Analysis: North America
        18.1.3    Market Share Analysis: Europe
        18.1.4    Market Share Analysis: Asia Pacific
        18.1.5    Market Share Analysis: Others
    18.2    Agilent Technologies, Inc. 
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Company News and Development
        18.2.5    Certifications 
    18.3    Thermo Fisher Scientific, Inc. 
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Company News and Development
        18.3.5    Certifications
    18.4    Bruker Corporation  
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Company News and Development
        18.4.5    Certifications
    18.5    Shimadzu Corporation 
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Company News and Development
        18.5.5    Certifications
    18.6    Bio-Rad Laboratories, Inc. 
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Company News and Development
        18.6.5    Certifications
    18.7    Metabolon, Inc. 
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Company News and Development
        18.7.5    Certifications
    18.8    Danaher Corporation  
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic
        18.8.4    Company News and Development
        18.8.5    Certifications
    18.9    PerkinElmer Inc.  
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Company News and Development
        18.9.5    Certifications
    18.10    Human Metabolome Technologies  
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Company News and Development
        18.10.5    Certifications 
    18.11    Bioanalytical Systems, Inc.  
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Company News and Development
        18.11.5    Certifications 
19    Global Metabolomics Market – Distribution Model (Additional Insight)
    19.1     Overview 
    19.2     Potential Distributors 
    19.3     Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders  (KOL) Insights (Additional Insight)

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.